Arcus biosciences inc.

Major-Pharmaceuticals

RCUS


3928 Point Eden Way
Hayward , CA 94545

Executive/
Director

Price

  • Last Close
  • $ 15.07
    $ -0.07 -0.46 %
    Jan 3, 2025
  • 52-Week High/Low
  • $22.51 - $13.44
  • YTD
  • 1.1%

  • Trading Volume
  • 7,820
  • Market Cap Full
  • $ 1.1B
  • Shares Outstanding
  • 74.9M
    Nov 1, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - 16% -5% 7.7% -21.7% -11.8% -0.9% 1.1%
Q2 - - -23% -33% 4% -1.8% -20% 11.3% -18% -
Q3 - - 11.3% 9.7% 8% 27% 3.2% -11.6% 5.4% -
Q4 - - -25.7% 13.8% 51.5% 16.1% -20.9% 10.5% -16.7% -
J F M A M J J A S O N D
2025 1.1% - - - - - - - - - - -
2024 -20.7% 26.4% -1.1% -22.5% 2.7% 0.8% 8.3% 5.4% - - - -3.5%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%-7%158%56%-49%-8%-22%1%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -1.37 -0.41 -0.63 -1.08 -0.96 -1.09
Q2 - - -0.32 -0.64 -0.93 -1.09 -0.93 -1.04
Q3 - - -0.25 -0.51 0.03 -1.11 -0.9 -0.94
Q4 - - 0.51 -0.37 -0.71 3.99 -0.92 -
A 0 0 -1.4 -1.9 -2.2 0.7 -3.7 -3.07

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 44.5 46 70.9 71.1 73
Jun 44.5 44.5 46 71 71.7 73.1
Sep 44.5 45.8 64.9 71.4 72.2 74.5
Dec 44.5 45.9 64.9 70.2 72.4 74.9

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.4 1.7 3.4 1.5 0.5
Total Asset Turnover 0.1 0.2 0.1 0.1 -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 21.5 54 124 22.3 11
Equity multiplier 0.4 0.3 0.1 0.1 0.1